EXP1 New Technologies in Dermatology
DESCRIPTION
In this session learners will have an opportunity to explore emerging technologies that likely will be integrated in to clinical practice by 2030.
LEARNING OBJECTIVES
Explore emerging technologies that are likely to be routine in clinical practice in the next 5 years.
Discuss novel diagnostic and therapeutic approaches in dermatology.
Review new trends in aesthetics
SCHEDULE
10:00 AM
Future Technologies Coming soon to Your Practice
Ashish Bhatia, MD, FAAD
10:10 AM
What You May Be Using Soon In Your Practice
Ashish Bhatia, MD, FAAD
10:20 AM
Questions and Answers
Ashish Bhatia, MD, FAAD
DIRECTOR
Ashish Bhatia, MD, FAAD
Oak Dermatology
DISCLOSURES
Ashish Bhatia, MD, FAAD
AbbVie – Other(Grants/Research Funding), Stockholder Public Company(Stock Options); Alastin Skincare, Inc – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Grants/Research Funding); Allergan, Inc – Advisory Board(Honoraria), Speaker(Honoraria); Allergan, Inc. – Consultant(Honoraria); Arcutis Biotherapeutics – Consultant (1099 relationship)(Fees); Avita Medical – Consultant (1099 relationship)(Fees), Other(Grants/Research Funding); Bausch Health – Consultant (1099 relationship)(Fees), Stockholder Public Company(Stock); BiaCure Therapies Inc – Consultant (1099 relationship)(Fees); Biofrontera – Consultant (1099 relationship)(Fees); BioPhotas Inc. – Consultant (1099 relationship)(Fees); Bristol-Myers Squibb – Advisory Board(Honoraria); Caliway Biopharmaceuticals Co., Ltd – Advisory Board(No Compensation Received); Cutera, Inc. – Advisory Board(Honoraria), Consultant(Honoraria), Other(Grants/Research Funding), Speaker(Honoraria), Stockholder(Stock); Cynosure-Lutronic – Advisory Board(Honoraria); Cytrellis Biosystems, Inc – Advisory Board(Honoraria), Consultant(Honoraria), Stockholder Public Company(No Compensation Received); Derm Education Foundation – Advisory Board(Honoraria), Speaker(Honoraria); Derm.md, Inc. – Board of Directors(No Compensation Received), Stockholder(No Compensation Received); Eli Lilly – Other(Grants/Research Funding); Elsevier Inc. – Consultant(Honoraria); Emblation, Ltd. – Consultant (1099 relationship)(Fees), Other(Grants/Research Funding); Estee Lauder – Advisory Board(Honoraria); Feldan Therapeutics – Consultant (1099 relationship)(Fees); GenZum Life Sciences – Stockholder(No Compensation Received); Glo-Pharma, Inc. – Consultant (1099 relationship)(Fees); Impiricus – Consultant (1099 relationship)(Fees), Consultant (1099 relationship)(Stock); Jeisys – Consultant (1099 relationship)(Fees), Consultant (1099 relationship)(Honoraria); La Mer – Advisory Board(Honoraria); LMR Aesthetics – Consultant (1099 relationship)(Fees); Luminoma Diagnostics Ltd – Consultant (1099 relationship)(Fees); Medline Industries, Inc. – Advisory Board(Honoraria), Consultant(Honoraria), Other(Grants/Research Funding), Speaker(Honoraria); MiMedx Group, Inc – Consultant (1099 relationship)(Fees), Speaker(Honoraria); Novascan – Other(Grants/Research Funding); Ortho Dermatologics – Consultant(Honoraria), Speaker(Honoraria); OurSelf – Board of Directors(No Compensation Received); Ourself – Consultant (1099 relationship)(Fees); Paradigm Medical Communications, LLC – Speaker(Honoraria); Pfizer Inc. – Advisory Board(Honoraria); R2 Technologies – Other(Grants/Research Funding); RBC Consultants – Consultant (1099 relationship)(Fees); Regeneron Pharmaceuticals Inc – Consultant (1099 relationship)(Fees); Restore Biologics – Consultant (1099 relationship)(Fees); Revance Therapeutics, Inc. – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); SimSkin – Stockholder(No Compensation Received); SofWave – Consultant (1099 relationship)(Fees); Solta Medical – Advisory Board(Honoraria), Consultant(Honoraria); Sonoma Pharmaceuticals – Stockholder Public Company(No Compensation Received); Strata Skin Sciences – Advisory Board(Honoraria), Stockholder Public Company(Stock Options); Suasion Group LLC – Advisory Board(Fees); Theravant Corporation – Advisory Board(Honoraria), Board of Directors(No Compensation Received), Speaker(Honoraria), Stockholder(No Compensation Received); UCB – Advisory Board(Fees); Zalea, LLC – Stockholder Private Company(No Compensation Received);